1. Home
  2. JSPRW vs REGCO Comparison

JSPRW vs REGCO Comparison

Compare JSPRW & REGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPRW
  • REGCO
  • Stock Information
  • Founded
  • JSPRW N/A
  • REGCO N/A
  • Country
  • JSPRW United States
  • REGCO United States
  • Employees
  • JSPRW 45
  • REGCO 497
  • Industry
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • REGCO
  • Sector
  • JSPRW Health Care
  • REGCO
  • Exchange
  • JSPRW Nasdaq
  • REGCO Nasdaq
  • Market Cap
  • JSPRW N/A
  • REGCO N/A
  • IPO Year
  • JSPRW 2020
  • REGCO N/A
  • Fundamental
  • Price
  • JSPRW $0.17
  • REGCO $22.28
  • Analyst Decision
  • JSPRW
  • REGCO
  • Analyst Count
  • JSPRW 0
  • REGCO 0
  • Target Price
  • JSPRW N/A
  • REGCO N/A
  • AVG Volume (30 Days)
  • JSPRW N/A
  • REGCO N/A
  • Earning Date
  • JSPRW N/A
  • REGCO N/A
  • Dividend Yield
  • JSPRW N/A
  • REGCO N/A
  • EPS Growth
  • JSPRW N/A
  • REGCO N/A
  • EPS
  • JSPRW N/A
  • REGCO N/A
  • Revenue
  • JSPRW N/A
  • REGCO N/A
  • Revenue This Year
  • JSPRW N/A
  • REGCO N/A
  • Revenue Next Year
  • JSPRW N/A
  • REGCO N/A
  • P/E Ratio
  • JSPRW N/A
  • REGCO N/A
  • Revenue Growth
  • JSPRW N/A
  • REGCO N/A
  • 52 Week Low
  • JSPRW N/A
  • REGCO N/A
  • 52 Week High
  • JSPRW N/A
  • REGCO N/A
  • Technical
  • Relative Strength Index (RSI)
  • JSPRW N/A
  • REGCO 42.89
  • Support Level
  • JSPRW N/A
  • REGCO $21.84
  • Resistance Level
  • JSPRW N/A
  • REGCO $22.81
  • Average True Range (ATR)
  • JSPRW 0.00
  • REGCO 0.40
  • MACD
  • JSPRW 0.00
  • REGCO -0.04
  • Stochastic Oscillator
  • JSPRW 0.00
  • REGCO 36.36

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About REGCO Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

Share on Social Networks: